HYALURONIC ACID IN THE TREATMENT OF OSTEOARTHRITIS
- Authors: Yashina E.1
-
Affiliations:
- Issue: Vol 26, No 2 (2015)
- Pages: 58-61
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116202
- ID: 116202
Cite item
Open Access
Access granted
Abstract
The introduction of the hyaluronic acid is still considered as a qualitative breakthrough in the treatment of patients with osteoarthritis (OA). In order to obtain primary information to assess the market potential of hyaluronan in Russia in 20 centers in 18 cities conducted in-depth interviews with medical professionals as well as patients with OA. The data reveal a large potential market hyaluronic acid in Russia, which manifests itself as a high level of training, and a good response in patients with OA treatment. Proven efficacy and safety· as well as the diversity of the positive ef-fect is the basis for the widespread use of these drugs in OA for intraarticular injection as Suplazin and Suplazin 1-SHOT (Вioniche teoranta Co., Ireland).
Keywords
Full Text
References
- Adatia A., Rainsford K., Kean W. Osteoarthritis of the knee and hip. Part I: aetiology and pathogenesis as a basis for pharmacotherapy // J. Pharm. Pharmacol. - 2012; 64 (5): 617-25.
- EULAR Compendium on Rheumatic Disease. Ed. JWJ Bijsma // BMJ. - 2009; 824 р.
- Насонова В.А., Мендель О.И., Денисов Л.Н. и др. Остеоартроз и ожирение: клинико-патогенетические взаимосвязи // Профилактическая медицина. - 2011; 1: 29-37.
- Hochberg M., Altman R., April K. et al. ACR 2012 recommendations for the use of nonfarmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee // Arthritis Care Res. (Hoboken). - 2012; 64: 465-74.
- Barrett J., Siviero P. Retrospective study of outcomes in Hyalgan® - treated patients with osteoarthritis of the knee // Clin. Drug. Invest. - 2002; 22: 87-97.
- Marshall K. Intra-articular hyaluronan therapy // Foot Ankle Clin. N. Am. -2003; 8 (2): 221-32.
- Schumacher H., Meador R., Sieck M. et al. Pilot investigation of hyaluronate injections for first metacarpalcarpal osteoarthritis // J. Clin. Rheumatol. - 2004; 10 (2): 59-62.
- Silverstein E., Leger R., Shea K. The use of intra-articular hylan G-F 20 in the treat-ment of symptomaticosteoarthritis of the shoulder: a preliminary study // Am. J. Sports. Med. - 2007; 35 (6): 979-85.
- Maheu E., Hatimi J., Ravaud P. Intra-arthicular treatment for osteoarthritis for the knee: a French survey on use habits and perceptions by rheumatologists. Abstr. Ann. EULAR Congress. Berlin, 2004; 364.
- Сущук Е.А. Оценка эффективности препаратов гиалуроновой кислоты в лечении остеоартрита с позиций доказательной медицины [электронный ресурс] / М., 2007; режим доступа: http://www.go-on.rotta.ru
- Hamburger M., Lakhanpal S., Mooar P. et al. Intra-articular hyaluronans: a re-view of product-specific safety profiles // Semin. Arthritis Rheum. - 2003; 32 (5): 296-309.
- Gosh P., Guidolin D. Potential Mechanism of Action of Intra-articular Hyaluronan Therapy in Osteoarthritis: Are the Effects Moleculasr Weight Dependent? // Semin. Arthritis Rheum. - 2002; 32 (1): 10-37.
- Страхов М.А., Скороглядов А.В. Современные тенденции использования средств, замещающих синовиальную жидкость, на основе связанной гиалуроновой кислоты в лечении пациентов с травмами и заболеваниями опорнодвигательного аппарата // Вестн. травматол. и ортопед. им. Н.Н. Приорова. - 2013; 4: 2-7.
- Moreland L. Intra-articular hyaluronan (hyaluronic acid) and hylans for the trearment of osteoarthritis: mechanisms of actions // Arthritis Res. Ther. - 2003; 5: 54-67.
- Gydek A. et al. Efficacy and safety of intra-articular use of Hyaluronic acid (Suplasyn) in the treatment of knee osteoarthritis // Przegl. Lek. - 2011; 68 (6): 307-10.
- Blanch-Rubiô J., Badstübner R., Schnee B. et al. ASKOT study: Effectiveness and safety of a 1-shot injection of sodium Hyaluronate for knee osteoarthritis treatment [электронныйресурс] / Springer Experience & Drug Evidence - режим доступа: http://www.orthops.si/documents/suplasyn-askot_2012_blanch.pdf
- Chevalier X. et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with simptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo contolled trial // Ann. Rheum. Dis. - 2010; 69:
Supplementary files
